{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:21:19Z","timestamp":1777396879646,"version":"3.51.4"},"reference-count":50,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2019,5,7]]},"DOI":"10.3233\/jad-181000","type":"journal-article","created":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T13:48:13Z","timestamp":1554212893000},"page":"297-309","source":"Crossref","is-referenced-by-count":23,"title":["Chronic Angiotensin 1-7 Infusion Prevents Angiotensin-II-Induced Cognitive Dysfunction and Skeletal Muscle Injury in a Mouse Model of Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"69","author":[{"given":"Cheng","family":"Cao","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Chuo-ku, Kumamoto, Japan"},{"name":"Program for Leading Graduate Schools \u201cHIGO (Health life Science: Interdisciplinary and Glocal Oriented) Program\u201d, Kumamoto University, Chuo-ku, Kumamoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Chuo-ku, Kumamoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenyu","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Chuo-ku, Kumamoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushin","family":"Takemoto","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Chuo-ku, Kumamoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shokei","family":"Kim-Mitsuyama","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Molecular Therapeutics, Kumamoto University Graduate School of Medical Sciences, Chuo-ku, Kumamoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-181000_ref1","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","article-title":"The cellular phase of Alzheimer\u2019s disease","volume":"164","author":"De Strooper","year":"2016","journal-title":"Cell"},{"key":"10.3233\/JAD-181000_ref2","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.jacc.2016.08.073","article-title":"Abeta amyloid pathology affects the hearts of patients with Alzheimer\u2019s disease: mind the heart","volume":"68","author":"Troncone","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.3233\/JAD-181000_ref3","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S2213-8587(15)00033-9","article-title":"BMI and risk of dementia in two million people over two decades: a retrospective cohort study","volume":"3","author":"Qizilbash","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.3233\/JAD-181000_ref4","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1001\/archneurol.2010.38","article-title":"Reduced lean mass in early Alzheimer disease and its association with brain atrophy","volume":"67","author":"Burns","year":"2010","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-181000_ref5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jalz.2014.04.514","article-title":"At the interface of sensory and motor dysfunctions and Alzheimer\u2019s disease","volume":"11","author":"Albers","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-181000_ref6","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nrneurol.2017.111","article-title":"A systemic view of Alzheimer disease - insights from amyloid-beta metabolism beyond the brain","volume":"13","author":"Wang","year":"2017","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-181000_ref7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jalz.2008.10.004","article-title":"Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer\u2019s disease","volume":"5","author":"Roher","year":"2009","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-181000_ref8","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0002-9440(10)64947-4","article-title":"Elevated abeta42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of AbetaPP metabolism","volume":"156","author":"Kuo","year":"2000","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-181000_ref9","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/341226a0","article-title":"Amyloid beta-protein deposition in tissues other than brain in Alzheimer\u2019s disease","volume":"341","author":"Joachim","year":"1989","journal-title":"Nature"},{"key":"10.3233\/JAD-181000_ref10","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","article-title":"Preclinical Alzheimer\u2019s disease: Definition, natural history, and diagnostic criteria","volume":"12","author":"Dubois","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-181000_ref11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-181000_ref12","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","article-title":"Dementia prevention, intervention, and care","volume":"390","author":"Livingston","year":"2017","journal-title":"Lancet"},{"key":"10.3233\/JAD-181000_ref13","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3389\/fphar.2018.00440","article-title":"Targeting renin-angiotensin system against Alzheimer\u2019s disease","volume":"9","author":"Gebre","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.3233\/JAD-181000_ref14","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1152\/physrev.00038.2017","article-title":"Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology","volume":"98","author":"Forrester","year":"2018","journal-title":"Physiol Rev"},{"key":"10.3233\/JAD-181000_ref15","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3233\/JAD-171119","article-title":"The coming of age of the angiotensin hypothesis in Alzheimer\u2019s disease: progress toward disease prevention and treatment?","volume":"62","author":"Kehoe","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-181000_ref16","doi-asserted-by":"crossref","first-page":"e004897","DOI":"10.1161\/JAHA.116.004897","article-title":"Detrimental effects of centrally administered angiotensin ii are enhanced in a mouse model of Alzheimer disease independently of blood pressure","volume":"6","author":"Takane","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.3233\/JAD-181000_ref17","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1016\/j.febslet.2012.09.004","article-title":"Central angiotensin II-induced Alzheimer-like tau phosphorylation in normal rat brains","volume":"586","author":"Tian","year":"2012","journal-title":"FEBS Lett"},{"key":"10.3233\/JAD-181000_ref18","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/ijcp.12626","article-title":"Impact of renin-angiotensin system-targeting antihypertensive drugs on treatment of Alzheimer\u2019s disease: a meta-analysis","volume":"69","author":"Ye","year":"2015","journal-title":"Int J Clin Pract"},{"key":"10.3233\/JAD-181000_ref19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s40263-015-0230-6","article-title":"Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms","volume":"29","author":"Rouch","year":"2015","journal-title":"CNS Drugs"},{"key":"10.3233\/JAD-181000_ref20","doi-asserted-by":"crossref","first-page":"b5465","DOI":"10.1136\/bmj.b5465","article-title":"Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: Prospective cohort analysis","volume":"340","author":"Li","year":"2010","journal-title":"BMJ"},{"key":"10.3233\/JAD-181000_ref21","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/HJH.0b013e3283603f53","article-title":"Antihypertensive classes, cognitive decline and incidence of dementia: A network meta-analysis","volume":"31","author":"Levi Marpillat","year":"2013","journal-title":"J Hypertens"},{"key":"10.3233\/JAD-181000_ref22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainres.2014.05.019","article-title":"Angiotensin-(1-7) improves cognitive function in rats with chronic cerebral hypoperfusion","volume":"1573","author":"Xie","year":"2014","journal-title":"Brain Res"},{"key":"10.3233\/JAD-181000_ref23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.neuroscience.2017.01.027","article-title":"Angiotensin-(1-7) administration attenuates Alzheimer\u2019s disease-like neuropathology in rats with streptozotocin-induced diabetes via Mas receptor activation","volume":"346","author":"Chen","year":"2017","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-181000_ref24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3233\/JAD-150642","article-title":"Intracerebroventricular infusion of angiotensin-(1-7) ameliorates cognitive impairment and memory dysfunction in a mouse model of Alzheimer\u2019s disease","volume":"53","author":"Uekawa","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-181000_ref25","doi-asserted-by":"crossref","first-page":"e003154","DOI":"10.1161\/JAHA.115.003154","article-title":"High-fat-diet intake enhances cerebral amyloid angiopathy and cognitive impairment in a mouse model of Alzheimer\u2019s disease, independently of metabolic disorders","volume":"5","author":"Lin","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.3233\/JAD-181000_ref26","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-181000_ref27","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1161\/HYPERTENSIONAHA.114.04139","article-title":"Hypertension accelerates the progression of Alzheimer-like pathology in a mouse model of the disease","volume":"65","author":"Cifuentes","year":"2015","journal-title":"Hypertension"},{"key":"10.3233\/JAD-181000_ref28","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/CIRCULATIONAHA.117.028145","article-title":"Plasminogen activator inhibitor type I Controls cardiomyocyte transforming growth factor-beta and cardiac fibrosis","volume":"136","author":"Flevaris","year":"2017","journal-title":"Circulation"},{"key":"10.3233\/JAD-181000_ref29","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1161\/HYPERTENSIONAHA.114.03415","article-title":"Angiotensin 1-7 reduces mortality and rupture of intracranial aneurysms in mice","volume":"64","author":"Pena Silva","year":"2014","journal-title":"Hypertension"},{"key":"10.3233\/JAD-181000_ref30","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1161\/HYPERTENSIONAHA.116.07620","article-title":"Vascular ADAM17 as a novel therapeutic target in mediating cardiovascular hypertrophy and perivascular fibrosis induced by angiotensin II","volume":"68","author":"Takayanagi","year":"2016","journal-title":"Hypertension"},{"key":"10.3233\/JAD-181000_ref31","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1038\/jcbfm.2013.143","article-title":"Age-related autoregulatory dysfunction and cerebromicrovascular injury in mice with angiotensin II-induced hypertension","volume":"33","author":"Toth","year":"2013","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.3233\/JAD-181000_ref32","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1161\/ATVBAHA.113.301320","article-title":"Angiotensin-(1-7) dose-dependently inhibits atherosclerotic lesion formation and enhances plaque stability by targeting vascular cells","volume":"33","author":"Yang","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.3233\/JAD-181000_ref33","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/HYPERTENSIONAHA.115.06935","article-title":"Chronic angiotensin-(1-7) improves insulin sensitivity in high-fat fed mice independent of blood pressure","volume":"67","author":"Williams","year":"2016","journal-title":"Hypertension"},{"key":"10.3233\/JAD-181000_ref34","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/ki.2014.274","article-title":"Angiotensin(1-7) attenuates the progression of streptozotocin-induced diabetic renal injury better than angiotensin receptor blockade","volume":"87","author":"Zhang","year":"2015","journal-title":"Kidney Int"},{"key":"10.3233\/JAD-181000_ref35","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nprot.2006.170","article-title":"Assessing nest building in mice","volume":"1","author":"Deacon","year":"2006","journal-title":"Nat Protoc"},{"key":"10.3233\/JAD-181000_ref36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12933-014-0157-0","article-title":"DPP-4 inhibitor linagliptin ameliorates cardiovascular injury in salt-sensitive hypertensive rats independently of blood glucose and blood pressure","volume":"13","author":"Koibuchi","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"10.3233\/JAD-181000_ref37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/ajh\/hpw099","article-title":"Transient mild cerebral ischemia significantly deteriorated cognitive impairment in a mouse model of Alzheimer\u2019s disease via angiotensin AT1 receptor","volume":"30","author":"Nakagawa","year":"2017","journal-title":"Am J Hypertens"},{"key":"10.3233\/JAD-181000_ref38","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12933-016-0473-7","article-title":"Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome","volume":"15","author":"Kusaka","year":"2016","journal-title":"Cardiovasc Diabetol"},{"key":"10.3233\/JAD-181000_ref39","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.nmd.2004.06.008","article-title":"Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse","volume":"14","author":"Briguet","year":"2004","journal-title":"Neuromuscul Disord"},{"key":"10.3233\/JAD-181000_ref40","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.exger.2016.11.012","article-title":"Chronic kidney disease accelerates cognitive impairment in a mouse model of Alzheimer\u2019s disease, through angiotensin II","volume":"87","author":"Nakagawa","year":"2017","journal-title":"Exp Gerontol"},{"key":"10.3233\/JAD-181000_ref41","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1177\/0271678X16667364","article-title":"Angiotensin II, hypertension and angiotensin II receptor antagonism: Roles in the behavioural and brain pathology of a mouse model of Alzheimer\u2019s disease","volume":"37","author":"Wiesmann","year":"2017","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.3233\/JAD-181000_ref42","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1007\/s12035-015-9260-9","article-title":"Angiotensin-(1-7) is reduced and inversely correlates with tau hyperphosphorylation in animal models of Alzheimer\u2019s disease","volume":"53","author":"Jiang","year":"2016","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-181000_ref43","doi-asserted-by":"crossref","first-page":"560","DOI":"10.2174\/138920312803582933","article-title":"Angiotensin II: role in skeletal muscle atrophy","volume":"13","author":"Cabello-Verrugio","year":"2012","journal-title":"Curr Protein Pept Sci"},{"key":"10.3233\/JAD-181000_ref44","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/med.21343","article-title":"Renin-angiotensin system: an old player with novel functions in skeletal muscle","volume":"35","author":"Cabello-Verrugio","year":"2015","journal-title":"Med Res Rev"},{"key":"10.3233\/JAD-181000_ref45","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1113\/expphysiol.2013.074336","article-title":"Autonomic, locomotor and cardiac abnormalities in a mouse model of muscular dystrophy: targeting the renin-angiotensin system","volume":"99","author":"Sabharwal","year":"2014","journal-title":"Exp Physiol"},{"key":"10.3233\/JAD-181000_ref46","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1042\/CS20140215","article-title":"Angiotensin-(1-7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism","volume":"128","author":"Cisternas","year":"2015","journal-title":"Clin Sci (Lond)"},{"key":"10.3233\/JAD-181000_ref47","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1007\/s00424-014-1617-9","article-title":"The angiotensin-(1-7)\/Mas axis reduces myonuclear apoptosis during recovery from angiotensin II-induced skeletal muscle atrophy in mice","volume":"467","author":"Meneses","year":"2015","journal-title":"Pflugers Arch"},{"key":"10.3233\/JAD-181000_ref48","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/cvr\/cvx013","article-title":"Increased BACE1-AS long noncoding RNA and beta-amyloid levels in heart failure","volume":"113","author":"Greco","year":"2017","journal-title":"Cardiovasc Res"},{"key":"10.3233\/JAD-181000_ref49","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2174\/1567205012666150204124852","article-title":"Age-dependent biochemical dysfunction in skeletal muscle of triple-transgenic mouse model of Alzheimer\u2019s disease","volume":"12","author":"Monteiro-Cardoso","year":"2015","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-181000_ref50","doi-asserted-by":"crossref","first-page":"13354","DOI":"10.18632\/oncotarget.7997","article-title":"Increased amyloid beta-peptide uptake in skeletal muscle is induced by hyposialylation and may account for apoptosis in GNE myopathy","volume":"7","author":"Bosch-Morato","year":"2016","journal-title":"Oncotarget"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-181000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:09:30Z","timestamp":1777370970000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-181000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,7]]},"references-count":50,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-181000","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,7]]}}}